Enzyme-assisted vitrectomy in enucleated pig eyes: A comparison of hyaluronidase, chondroitinase, and plasmin

Current Eye Research

Volumn 29, Issue 4-5, 2004, Pages 261-268

  Staubach, Flemming ^a,b   Nober, Veronika ^a   Janknecht, Peter ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Enzymes; Pigs; Vitrectomy; Vitreolysis

Indexed keywords

HYALURONIDASE; N ACETYLGALACTOSAMINE 4 SULFATASE; PLASMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC VALUE; ENUCLEATION; ENZYME ANALYSIS; ENZYME ASSISTED VITRECTOMY; INCUBATION TIME; MICROSCOPIC ANATOMY; NERVE FIBER MEMBRANE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA INJURY; SAFETY; STATISTICAL SIGNIFICANCE; SWINE; VITRECTOMY; VITREOUS DISEASE;

EID: 11844280358     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680490516747     Document Type: Article

References (48)

1. Wendel RT, Patel AC, Kelly NE, Salzano TC, Wells JW, Novack GD. Vitreous surgery for macular holes. [see comments.]. Comment in: Ophthalmology. 1993 Nov;100(11): 1607-8; 8233382. Ophthalmology. 1993;100:1671-1676.
2. Wendel RT, Patel AC, Kelly NE, Salzano TC, Wells JW, Novack GD. Vitreous surgery for macular holes. [see comments.]. Comment in: Ophthalmology. 1993 Nov;100(11): 1607-8; 8233382. Ophthalmology. 1993;100:1671-1676.
3. Han DP, Abrams GW, Aaberg TM. Surgical excision of the attached posterior hyaloid. Archives of Ophthalmology. 1988;106:998-1000.
4. Verstraten TC, Chapman C, Hartzer M, Winkler BS, Trese MT, Williams GA. Pharmacologic induction of posterior vitreous detachment in the rabbit. Archives of Ophthalmology. 1993;111:849-854.
5. Sebag J. Ageing of the vitreous. [Review] [39 refs]. Eye. 1987;1:254-262.
6. Sebag J. Age-related differences in the human vitreoretinal interface. Archives of Ophthalmology. 1991;109:966-971.
7. Cullinane AB, Cleary PE. Prevention of visual field defects after macular hole surgery. [see comments.]. Comment in: Br J Ophthalmol. 2000 Dec;84(12):1439; 11090490, Comment in: Br J Ophthalmol. 2001 Jan;85(1):121; 11133726. British Journal of Ophthalmology. 2000;84: 372-377.
8. Cullinane AB, Cleary PE. Prevention of visual field defects after macular hole surgery. [see comments.]. Comment in: Br J Ophthalmol. 2000 Dec;84(12):1439; 11090490, Comment in: Br J Ophthalmol. 2001 Jan;85(1):121; 11133726. British Journal of Ophthalmology. 2000;84: 372-377.
9. Cullinane AB, Cleary PE. Prevention of visual field defects after macular hole surgery. [see comments.]. Comment in: Br J Ophthalmol. 2000 Dec;84(12):1439; 11090490, Comment in: Br J Ophthalmol. 2001 Jan;85(1):121; 11133726. British Journal of Ophthalmology. 2000;84: 372-377.
10. Wiedemann P, Weller M, Heimann K. [Proliferative vitreoretinopathy: new discoveries in pathophysiology and therapy]. [Review] [46 refs] [German]. Klinische Monatsblatter fur Augenheilkunde. 1990;197:355-361.
11. Wiedemann P. Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. [Review] [130 refs]. Survey of Ophthalmology. 1992;36:373-384.
12. Hines J, Vinores SA, Campochiaro PA. Evolution of morphologic changes after intravitreous injection of gentamicin. Current Eye Research. 1993;12:521-529.
13. Garcia-Layana A, Pastor JC, Saornil MA, Gonzalez G. Porcine model of proliferative vitreoretinopathy with platelets. Current Eye Research. 1997;16:556-563.
14. Hikichi T, Yanagiya N, Kado M, Akiba J, Yoshida A. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina. 1999;19:55-58.
15. Hikichi T, Kado M, Yoshida A. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit. Retina. 2000;20:195-198.
16. Bishop PN, McLeod D, Reardon A. Effects of hyaluronan lyase, hyaluronidase, and chondroitin ABC lyase on mammalian vitreous gel. Investigative Ophthalmology & Visual Science. 1999;40:2173-2178.
17. Sebag J. Pharmacologic vitreolysis [editorial; comment]. [Review] [17 refs] Comment on: Retina 1998;18(1):7-15, Comment on: Retina 1998;18(1):16-22. Retina. 1998;18:1-3.
18. Sebag J. Pharmacologic vitreolysis [editorial; comment]. [Review] [17 refs] Comment on: Retina 1998;18(1):7-15, Comment on: Retina 1998;18(1):16-22. Retina. 1998;18:1-3.
19. Sebag J. Pharmacologic vitreolysis [editorial; comment]. [Review] [17 refs] Comment on: Retina 1998;18(1):7-15, Comment on: Retina 1998;18(1):16-22. Retina. 1998;18:1-3.
20. Trese MT, Williams GA, Hartzer MK. A new approach to stage 3 macular holes. Ophthalmology. 2000;107:1607-1611.
21. Foulds WS, Allan D, Moseley H, Kyle PM. Effect of intravitreal hyaluronidase on the clearance of tritiated water from the vitreous to the choroid. British Journal of Ophthalmology. 1985;69:529-532.
22. Gandorfer A, Putz E, Welge-Lussen U, Gruterich M, Ulbig M, Kampik A. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. [see comments.]. Comment in: Br J Ophthalmol. 2001 Jan;85(1):1-2; 11133700. British Journal of Ophthalmology. 2001;85: 6-10.
23. Gandorfer A, Putz E, Welge-Lussen U, Gruterich M, Ulbig M, Kampik A. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. [see comments.]. Comment in: Br J Ophthalmol. 2001 Jan;85(1):1-2; 11133700. British Journal of Ophthalmology. 2001;85: 6-10.
24. Gottlieb JL, Antoszyk AN, Hatchell DL, Saloupis P. The safety of intravitreal hyaluronidase. A clinical and histologic study. Investigative Ophthalmology & Visual Science. 1990;31:2345-2352.
25. Hageman G, SR R. Chondroitinase-mediated disinsertion of the primate vitreous body. Investigative Ophthalmology & Visual Science (suppl). 1994;35:1260.
26. Harooni M, McMillan T, Refojo M. Efficacy and safety of enzymatic posterior vitreous detachment by intravitreal injection of hyaluronidase. [comment]. Comment in: Retina. 1998;18(1):1-3. Retina. 1998;18:16-22.
27. Harooni M, McMillan T, Refojo M. Efficacy and safety of enzymatic posterior vitreous detachment by intravitreal injection of hyaluronidase. [comment]. Comment in: Retina. 1998;18(1):1-3. Retina. 1998;18:16-22.
28. Heegaard S, Jensen OA, Prause JU. Structure and composition of the inner limiting membrane of the retina. SEM on frozen resin-cracked and enzyme-digested retinas of Macaca mulatta. Graefes Archive for Clinical & Experimental Ophthalmology. 1986;224:355-360.
29. Menzel EJ, Farr C. Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. [Review] [56 refs]. Cancer Letters. 1998;131:3-11.
30. Tezel TH, Del Priore LV, Kaplan HJ. Posterior vitreous detachment with dispase [see comments]. Comment in: Retina 1998;18(1):1-3. Retina. 1998;18:7-15.
31. Tezel TH, Del Priore LV, Kaplan HJ. Posterior vitreous detachment with dispase [see comments]. Comment in: Retina 1998;18(1):1-3. Retina. 1998;18:7-15.
32. Fechner PU, Wichmann W. Intraocular use of hyaluronidase to dissolve sodium hyaluronic acid. Journal of Refractive Surgery. 1997;13:502-503.
33. Hesse L, Chofflet J, Kroll P. Tissue plasminogen activator as a biochemical adjuvant in vitrectomy for proliferative diabetic vitreoretinopathy. German Journal of Ophthalmology. 1995;4:323-327.
34. Russell SR, Shepherd JD, Hageman GS. Distribution of glycoconjugates in the human retinal internal limiting membrane. Investigative Ophthalmology & Visual Science. 1991;32:1986-1995.
35. AG C-G. Bestandteile der lebenden Materie - Enzyme. In: Wissenschaftliche Tabellen Geigy 2. Basel; 1982: 109.
36. Henke SE, Demarais S. Changes in vitreous humor associated with postmortem interval in rabbits. American Journal of Veterinary Research. 1992;53:73-77.
37. Hikichi T, Akiba J, Ueno N, Yoshida A, Chakrabarti B. Cross-linking of vitreous collagen and degradation of hyaluronic acid induced by bilirubin-sensitized photochemical reaction. Japanese Journal of Ophthalmology. 1997;41:154-159.
38. Hesse L, Nebeling B, Schroeder B, Heller G, Kroll P. Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy. Experimental Eye Research. 2000;70:31-39.
39. Nishikawa S, Tamai M. Ultrastructure of hyaluronic acid and collagen in the human vitreous. Current Eye Research. 1996:15:37-43.
40. Kang SW, Hyung SM, Choi MY, Lee J. Induction of vitreolysis and vitreous detachment with hyaluronidase and perfluoropropane gas. Korean Journal of Ophthalmology. 1995;9:69-78.
41. Winkler BS, Cohn EM. Hyaluronidase and retinal function. Archives of Ophthalmology. 1985;103:1743-1746.
42. Scott JE. The chemical morphology of the vitreous. [Review] [13 refs]. Eye. 1992;6:553-555.
43. Hollyfield JG, Rayborn ME, Tammi M, Tammi R. Hyaluronan in the interphotoreceptor matrix of the eye: species differences in content, distribution, ligand binding and degradation. Experimental Eye Research. 1998;66:241-248.
44. Jorge R, Oyamaguchi EK, Cardillo JA, Gobbi A, Laicine EM, Haddad A. Intravitreal injection of dispase causes retinal hemorrhages in rabbit and human eyes. Current Eye Research. 2003;26:107-112.
45. Foos RY. Vitreoretinal juncture; topographical variations. Investigative Ophthalmology. 1972;11:801-808.
46. Beauchemin ML. The fine structure of the pig's retina. Albrecht Von Graefes Archiv fur Klinische und Experimentelle Ophthalmologie. 1974;190:27-45.
47. Sebag J. Is pharmacologic vitreolysis brewing? [comment]. Comment on: Retina. 2001;21(4):324-31; PMID: 11508877. Retina. 2002;22:1-3.
48. Sebag J. Is pharmacologic vitreolysis brewing? [comment]. Comment on: Retina. 2001;21(4):324-31; PMID: 11508877. Retina. 2002;22:1-3.